Cognitive effects of cilostazol in Alzheimer's dementia patients with peripheral arterial occlusive disease: A case–control study

In AD patients with peripheral arterial occlusive disease who have received Food and Drug Administration-approved pharmacotherapy, cilostazol, as an antiplatelet, may help to preserve general cognitive function, with significant preservation in category fluency. Geriatr Gerontol Int 2023; 23: 194-199.